Envoy Medical Inc. said three new patents were issued, including one U.S. patent (No. 12,544,564) covering improved input signal-to-noise ratio processing for cochlear implant systems and two Hong Kong patents: HK40102155 on coordinating a cochlear implant with an external auditory aid by adjusting the processor transfer function, and HK40107235 on electrode impedance diagnostics used to set stimulation parameters such as compliance voltage. The company said the additions expand its intellectual property portfolio and strengthen its competitive position in fully implanted hearing solutions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202602230800NEWSFILECNPR____20260223_284835_1) on February 23, 2026, and is solely responsible for the information contained therein.